RESUMO
Human taeniosis due to Taenia saginata is cosmopolitan where beef is consumed; however, there is little or no information on the symptomatology over the early time-course of human infection. Copro-antigen detection is very useful in community screening for human taeniosis, particularly for T. solium, but there are no data on copro-antigen detection in pre-patent infection. In order to provide insight into this, a voluntary self-infection with T. saginata was undertaken and monitored over a 6-month period using a copro-antigen enzyme-linked immunosorbent assay (ELISA) that we developed using anti-T. saginata antibody based reagents. Tapeworm patency, defined as first proglottid appearance, occurred on day 86 post-infection (pi) and was followed by almost daily release of proglottids (range 1-8) until termination using praziquantel on day 180 pi. The first 10 weeks post-infection (wpi) were essentially asymptomatic, followed by main symptoms of involuntary proglottid discharge throughout the infection period, and abdominal discomfort peaking around 15-19 wpi. Copro-antigens could not be reliably detected until 2 weeks before proglottid patency but then remained highly elevated over the next 15 weeks until treatment. Copro-antigen levels reverted to negative 4 days post-treatment. This time-course study suggests that although copro-antigen ELISA is an excellent diagnostic tool for established patent infections of T. saginata, it may not be reliable for faecal antigen detection in the early infection phase prior to proglottid release for T. saginata and other human taenioses.
Assuntos
Antígenos de Helmintos/análise , Taenia saginata/isolamento & purificação , Teníase/diagnóstico , Animais , Ensaio de Imunoadsorção Enzimática , Fezes/parasitologia , Voluntários Saudáveis , Humanos , Taenia saginata/fisiologia , Teníase/parasitologiaRESUMO
Two commercial prednisone tablets were studied which had previously been shown by Sullivan et al.5,6 to have the slowest and fastest in vitro rates of dissolution, and the slowest and fastest rise to peak plasma prednisolone concentrations in human beings. The effect of food on the adsorption of these two tablets was studied in a crossover study, which also repeated the fasting conditions used by Sullivan et al.6 Marked differences in mean prednisolone plasma concentrations during the 0- to 2-hour absorption phase were observed between the two tablets again, but food did not affect either tablet with respect to mean plasma prednisolone concentrations.
Assuntos
Alimentos , Prednisona/metabolismo , Adulto , Disponibilidade Biológica , Ensaios Clínicos como Assunto , Meia-Vida , Humanos , Masculino , Prednisolona/sangue , Prednisona/administração & dosagem , Solubilidade , Comprimidos , Fatores de TempoRESUMO
An extensive survey of radioimmunoassay calibration data for prednisolone, prednisone and digoxin indicated that the common practice of preparing calibration curves with individual subject's pre-dose plasma or serum, and using this to estimate unknown concentrations for the same subject, is not supported by statistical considerations. Preparation of calibration plots from pooled data is better because this introduces less bias in estimated concentrations. Such a method also saves a great deal of time, since it is not necessary to repeat the calibration procedure each time, "unknowns" are being assayed. The data suggest that there is no optimum calibration plot for all radioimmunoassays. Rather, each antibody-drug combination should be investigated thoroughly to determine the best calibration plot for the particular combination. We found that the best calibration plots are: the logistic-logarithmic plot for prednisolone; nonlinear least squares fit to a polyexponential equation for nisolone; nonlinear least squares fit to a polyexponential equation for prednisone; and a weighted least squares regression of normalized % bound versus concentration for figoxin. The error in the radioimmunoassay is usually concentration-dependent, and, in certain regions of the standard curve, is larger than the literature indicates, since, frequently, the error has been gauged from % bound values, but should be guaged from inversely-estimated concentrations.
Assuntos
Digoxina/sangue , Prednisolona/sangue , Prednisona/sangue , Estudos de Avaliação como Assunto , Humanos , Cinética , Microquímica , Controle de Qualidade , Radioimunoensaio/métodos , Estatística como AssuntoRESUMO
A comparison was made between plasma concentrations of prednisolone measured by both competitive protein binding radioassay (CPB) and radioimmunoassay (RIA) and, with each assay, using a calibration curve generated from individual subject data and from pooling the individual calibration curva data. The plasma samples were obtained from six normal adult male volunteers who were pretreated with dexamethasone to suppress endogenous hydrocortisone and who then ingested 10 mg of prednisolone. Both the standard curve data and the plasma concentrations were evaluated statistically. It was shown that the CPB method has considerably greater precision than the RIA method and could be employed in bioavailability and pharmacokinetic studies of both prednisolone and prednisone. It was also shown that corticosteroid binding globulin cross-reacts considerably less with the major metabolite of prednisolone, 20beta-dihydroprednisolone, than the particular antiserum used in the RIA.
Assuntos
Prednisolona/sangue , Análise de Variância , Reações Cruzadas , Dexametasona , Humanos , Radioimunoensaio/métodos , Ensaio Radioligante/métodosRESUMO
This study was completed by Dr Speakman while he was Associated Professor and Chairman of the Department of Rehabilitation in the Faculty of Medicine at the University of Zimbabwe. At that time Andrew Tembo was a physical therapy student and Sarah Hendry was an occupational therapy student. In recent years there has been increased interest in the attitudes held towards disabled persons by physiotherapy students and physiotherapists. Research on this topic has been conducted in Canada, Australia, the USA, and South Africa. In every one of these studies the instrument used to measure attitudes was one of the three forms of the Attitudes Toward Disabled Persons Scales (ATDPS). A major shortcoming of self-report scales such as the ATDPS is that they can often be faked. If the scales contain "transparent" statements, that is, statements to which the socially desirable answer is obvious or seems obvious, the subjects may be tempted to fake their responses. It is therefore important to determine if a self-report scale can be faked. Of the five studies that have been undertaken to determine if the ATDPS are fakeable, four have indicated that they are not, while one has demonstrated that they are. As it seems that the ATDPS will continue to be the instrument of choice in the measurement of attitudes toward disabled persons by physiotherapy students and physiotherapists, it is important that this question be resolved.
Assuntos
Atitude do Pessoal de Saúde , Enganação , Pessoas com Deficiência , Modalidades de Fisioterapia , Estudantes de Ciências da Saúde/psicologia , Adolescente , Adulto , Viés , Feminino , Humanos , Masculino , Reprodutibilidade dos Testes , Inquéritos e QuestionáriosRESUMO
Using a crossover experimental design, the absorption profile of griseofulvin was assessed in human volunteers after oral administration of a 500 mg dose of the antifungal antibiotic as capsules of the anhydrous (nonsolvated)-and monochloroform solvate forms of the drug. The maximum body level of drug and the rate and extent of griseofulvin absorption (or bioavailability) were significantly increased after administration of the chloroform solvate as compared to that observed after administration of the nonsolvated form of the drug. The enhanced absorption of griseofulvin chloroformate correlated well with its enhanced solubility and dissolution rate at 37 degrees C in simulated intestinal fluid (20 mM sodium deoxycholate, pH 7.5). This is the first demonstration of a drug-organic solvate displaying improved gastrointestinal absorption characteristics over the anhydrous form of a drug.